Stay updated on Cabozantinib for PN in NF1: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The changes are limited to formatting and wording updates on the Study Details page, with no changes to study design, endpoints, eligibility criteria, or enrollment figures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T20:51:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    2%
    Check dated 2025-10-06T05:17:23.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 replacing Revision: v3.0.2. This is a version update to the core page metadata.
    Difference
    0.0%
    Check dated 2025-09-29T03:01:00.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    No substantive content changes. The page now shows Revision: v3.0.2 and removes the 'Back to Top' element, indicating a minor UI update.
    Difference
    0.1%
    Check dated 2025-09-14T19:05:41.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T15:07:56.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding new locations in Washington D.C. and St. Louis, while removing previous references to Neurofibromatosis Type 1. Additionally, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    1%
    Check dated 2025-08-31T11:47:51.000Z thumbnail image

Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.